葵花药业：8月27日召开董事会会议

Group 1 - The company, Kew Flower Pharmaceutical, announced on August 28 that its fifth board meeting was held via communication on August 27, 2025 [1] - The meeting reviewed the proposal regarding the full and summary report for the company's 2025 semi-annual report [1] Group 2 - The news highlights a significant medical advancement with the world's first successful transplantation of gene-edited pig lungs into a human [1] - The article includes a dialogue with key participants discussing the timeline for clinical application of this breakthrough [1]